Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 12:20 source : Www.biospace.com save search
Lilly's Retevmo® (selpercatinib) Demonstrates Superior Progression-Free Survival Compared to Approved Multikinase Inhibitors in RET-Mutant Medullary Thyroid Cancer
Published: 2023-08-22 (Crawled : 12:20) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.3%
H: 1.19%
C: 0.75%
retevmo approved cancer thyroid
Halberd’s Successful Completion of Sampling Phase Marks Major Milestone for Project at Mississippi State University (MSU)
Published: 2023-08-22 (Crawled : 12:20) - biospace.com/
HALB | $0.008 7.14% 220K
|
n/a
|
| O: 0.0%
H: 2.22%
C: 2.22%
state milestone
Nascent Biotech to Begin Phase II Clinical Trials for Brain Cancer
Published: 2023-08-22 (Crawled : 12:20) - biospace.com/
NBIO | $0.0924 15.32% 450
|
|
| O: 2.29%
H: 12.0%
C: 10.08%
biotech cancer trials
Pfizer Bispecific Drug Wins FDA Accelerated Approval for Multiple Myeloma
Published: 2023-08-15 (Crawled : 12:20) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.82%
H: 0.0%
C: 0.0%
fda drug approval
FSD Pharma Selected to Present its Phase 1 Data on Lucid-MS at MSMilan 2023 – 9th Joint ECTRIMS-ACTRIMS Meeting for October 11-13, 2023
Published: 2023-08-15 (Crawled : 12:20) - biospace.com/
HUGE | $0.6167 1.22% 29K
|
Process Industries
|
| O: -3.11%
H: 9.29%
C: 2.14%
pharma lucid-ms meeting
CNS Pharmaceuticals Reports Second Quarter 2023 Financial Results and Reiterates Upcoming Milestones
Published: 2023-08-14 (Crawled : 12:20) - biospace.com/
CNSP | $0.1934 -5.2% -5.48% 87K
|
Health Technology
|
| O: -2.46%
H: 2.53%
C: -10.61%
pharmaceuticals financial results
Biocept’s CNSide™ Cerebrospinal Fluid Assay Featured in Two Oral Presentations at the 2023 SNO/ASCO CNS Cancer Conference
Published: 2023-08-14 (Crawled : 12:20) - biospace.com/
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: 3.7%
H: 2.68%
C: -1.79%
conference cancer
Lilly Completes Acquisition of Sigilon Therapeutics
Published: 2023-08-14 (Crawled : 12:20) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 2.56%
H: 0.0%
C: 0.0%
acquisition therapeutics
Cybin Reports First Quarter Financial Results and Recent Business Highlights
Published: 2023-08-14 (Crawled : 12:20) - biospace.com/
CYBN | $0.3677 -0.6% 0.35% 1.8M
|
n/a
|
| O: 2.63%
H: 4.23%
C: 1.31%
business financial results
FDA Approves J&J’s Akeega for BRCA-Positive Prostate Cancer
Published: 2023-08-14 (Crawled : 12:20) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: 0.0%
fda cancer
Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business Update
Published: 2023-08-10 (Crawled : 12:20) - biospace.com/
APVO 4 d | $0.721 -6.36% -6.8% 230K
|
Health Technology
|
| O: -3.0%
H: 7.44%
C: -6.89%
business update therapeutics financial results
Milestone Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Corporate Update
Published: 2023-08-10 (Crawled : 12:20) - biospace.com/
MIST | $1.64 0.61% 0.61% 30K
|
Health Technology
|
| O: 2.56%
H: 4.06%
C: 3.12%
update pharmaceuticals financial results milestone
Rocket Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Progress
Published: 2023-08-10 (Crawled : 12:20) - biospace.com/
RCKT M | $22.82 -2.81% -2.89% 960K
|
Health Technology
|
| O: -2.36%
H: 2.84%
C: 1.33%
pharmaceuticals financial results
Protagonist Receives $34 Million from Warrant Exercises
Published: 2023-08-09 (Crawled : 12:20) - biospace.com/
PTGX | $25.61 1.55% 1.52% 450K
|
Health Technology
|
| O: -1.94%
H: 1.7%
C: 0.05%
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2023
Published: 2023-08-09 (Crawled : 12:20) - biospace.com/
SMMT A | $3.51 0.0% 1.7M
|
Health Technology
|
| O: -0.28%
H: 18.08%
C: 9.6%
six therapeutics financial results
Coya Therapeutics, Inc. Provides Business Update and Reports Q2 2023 Unaudited Financial Results
Published: 2023-08-08 (Crawled : 12:20) - biospace.com/
COYA | $7.87 -6.75% -7.24% 54K
|
|
| O: 5.71%
H: 0.0%
C: -4.18%
business update financial results
Viatris Reports Strong Financial and Operational Results for Second Quarter 2023 and Reaffirms Full-Year 2023 Guidance Ranges[1]
Published: 2023-08-07 (Crawled : 12:20) - biospace.com/
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 2.46%
H: 5.81%
C: 1.38%
financial results
Verrica Pharmaceuticals Announces Acceptance of Abstract Featuring Clinical Data of VP-315 for the Treatment of Basal Cell Carcinoma
Published: 2023-08-03 (Crawled : 12:20) - biospace.com/
VRCA | $6.96 0.87% 0.72% 130K
|
Health Technology
|
| O: -1.28%
H: 3.16%
C: -1.12%
vp-315 cell treatment pharmaceuticals
Teleflex Announces Quarterly Dividend - August 3, 2023
Published: 2023-08-03 (Crawled : 12:20) - biospace.com/
TFX | $206.56 -0.4% 0.0% 420K
|
Health Technology
|
| O: -1.13%
H: 0.08%
C: -2.26%
Elevation Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Business Achievements
Published: 2023-08-03 (Crawled : 12:20) - biospace.com/
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: 0.92%
H: 0.0%
C: 0.0%
business financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.